Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijing Zhang

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
BMC Cancer|August 11, 2023
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort studyKaili Zhong, Yanyan Shi, Yuhuan Gao, et al.
Oncoimmunology|July 29, 2016
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localizationFan Zhang, Junlan Yang, Huafei Li, et al.
Neuro-Oncology|August 9, 2022
False-negative and false-positive outcomes of computer-aided detection on brain metastasis: Secondary analysis of a multicenter, multireader studyXiao Luo, Yadi Yang, Shaohan Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Clinical features of rituximab plus chemotherapy as first-line treatment in patients with diffuse large B-cell lymphoma]Jifeng Feng, Jianqiu Wu, Yongping Song, et al.
Cancer Science|October 11, 2018
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failureShaoxuan Hu, Yuqin Song, Xiuhua Sun, et al.
BMC Cancer|July 28, 2016
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Yongping Song, Liping Su, et al.
Haematologica|January 18, 2024
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumorsYuqin Song, Junning Cao, Qingyuan Zhang, et al.
Neuro-Oncology|July 11, 2024
Automated segmentation of brain metastases with deep learning: A multi-center, randomized crossover, multi-reader evaluation studyXiao Luo, Yadi Yang, Shaohan Yin, et al.
Heliyon|April 24, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest groupHuisheng Ai, Nelson J Chao, David A Rizzieri, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
BMC Cancer|August 11, 2023
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort studyKaili Zhong, Yanyan Shi, Yuhuan Gao, et al.
Oncoimmunology|July 29, 2016
Combating rituximab resistance by inducing ceramide/lysosome-involved cell death through initiation of CD20-TNFR1 co-localizationFan Zhang, Junlan Yang, Huafei Li, et al.
Neuro-Oncology|August 9, 2022
False-negative and false-positive outcomes of computer-aided detection on brain metastasis: Secondary analysis of a multicenter, multireader studyXiao Luo, Yadi Yang, Shaohan Yin, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2014
[Clinical features of rituximab plus chemotherapy as first-line treatment in patients with diffuse large B-cell lymphoma]Jifeng Feng, Jianqiu Wu, Yongping Song, et al.
Cancer Science|October 11, 2018
Primary breast diffuse large B-cell lymphoma in the rituximab era: Therapeutic strategies and patterns of failureShaoxuan Hu, Yuqin Song, Xiuhua Sun, et al.
BMC Cancer|July 28, 2016
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional studyJianqiu Wu, Yongping Song, Liping Su, et al.
Haematologica|January 18, 2024
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumorsYuqin Song, Junning Cao, Qingyuan Zhang, et al.
Neuro-Oncology|July 11, 2024
Automated segmentation of brain metastases with deep learning: A multi-center, randomized crossover, multi-reader evaluation studyXiao Luo, Yadi Yang, Shaohan Yin, et al.
Heliyon|April 24, 2023
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest groupHuisheng Ai, Nelson J Chao, David A Rizzieri, et al.
Pageof 13